FDA Clearance Tracker · P000021-S028
DIMENSION VISTA TPSA ASSAY
Last checked: Nov 20, 2026Latest source record: Oct 19, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Oct 19, 2016
Approved
Time to decision
317 days
Received Dec 7, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000021-S028
- Device name
- DIMENSION VISTA TPSA ASSAY
- Applicant
- Siemens Healthcare Diagnostics
- Applicant location
- Newark, DE
- Received
- Dec 7, 2015
- Decided
- Oct 19, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000021
Device type
- Device type
- Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer (MTF)
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for a device modification to add a new photomultiplier tube (PMT) to the Dimension Vista 1500 and 500 Systems.
Source documents
Other decisions for Siemens Healthcare Diagnostics
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260674 · Decided Nov 6, 2026 · 249 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.